These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 18668144)
61. Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice. Scallan CD; Jiang H; Liu T; Patarroyo-White S; Sommer JM; Zhou S; Couto LB; Pierce GF Blood; 2006 Mar; 107(5):1810-7. PubMed ID: 16249376 [TBL] [Abstract][Full Text] [Related]
62. Comparative analysis of adeno-associated virus capsid stability and dynamics. Rayaprolu V; Kruse S; Kant R; Venkatakrishnan B; Movahed N; Brooke D; Lins B; Bennett A; Potter T; McKenna R; Agbandje-McKenna M; Bothner B J Virol; 2013 Dec; 87(24):13150-60. PubMed ID: 24067976 [TBL] [Abstract][Full Text] [Related]
63. Coevolution of Adeno-associated Virus Capsid Antigenicity and Tropism through a Structure-Guided Approach. Havlik LP; Simon KE; Smith JK; Klinc KA; Tse LV; Oh DK; Fanous MM; Meganck RM; Mietzsch M; Kleinschmidt J; Agbandje-McKenna M; Asokan A J Virol; 2020 Sep; 94(19):. PubMed ID: 32669336 [TBL] [Abstract][Full Text] [Related]
64. Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models. Markusic DM; Nichols TC; Merricks EP; Palaschak B; Zolotukhin I; Marsic D; Zolotukhin S; Srivastava A; Herzog RW J Transl Med; 2017 May; 15(1):94. PubMed ID: 28460646 [TBL] [Abstract][Full Text] [Related]
65. Modification and labeling of AAV vector particles. Büning H; Bolyard CM; Hallek M; Bartlett JS Methods Mol Biol; 2011; 807():273-300. PubMed ID: 22034035 [TBL] [Abstract][Full Text] [Related]
66. A dual role of EGFR protein tyrosine kinase signaling in ubiquitination of AAV2 capsids and viral second-strand DNA synthesis. Zhong L; Zhao W; Wu J; Li B; Zolotukhin S; Govindasamy L; Agbandje-McKenna M; Srivastava A Mol Ther; 2007 Jul; 15(7):1323-30. PubMed ID: 17440440 [TBL] [Abstract][Full Text] [Related]
67. Adeno-Associated Virus (AAV) Capsid Stability and Liposome Remodeling During Endo/Lysosomal pH Trafficking. Lins-Austin B; Patel S; Mietzsch M; Brooke D; Bennett A; Venkatakrishnan B; Van Vliet K; Smith AN; Long JR; McKenna R; Potter M; Byrne B; Boye SL; Bothner B; Heilbronn R; Agbandje-McKenna M Viruses; 2020 Jun; 12(6):. PubMed ID: 32575696 [TBL] [Abstract][Full Text] [Related]
68. Ex vivo intracoronary gene transfer of adeno-associated virus 2 leads to superior transduction over serotypes 8 and 9 in rat heart transplants. Raissadati A; Jokinen JJ; Syrjälä SO; Keränen MA; Krebs R; Tuuminen R; Arnaudova R; Rouvinen E; Anisimov A; Soronen J; Pajusola K; Alitalo K; Nykänen AI; Lemström K Transpl Int; 2013 Nov; 26(11):1126-37. PubMed ID: 24102821 [TBL] [Abstract][Full Text] [Related]
69. Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders. Pañeda A; Vanrell L; Mauleon I; Crettaz JS; Berraondo P; Timmermans EJ; Beattie SG; Twisk J; van Deventer S; Prieto J; Fontanellas A; Rodriguez-Pena MS; Gonzalez-Aseguinolaza G Hum Gene Ther; 2009 Aug; 20(8):908-17. PubMed ID: 19419275 [TBL] [Abstract][Full Text] [Related]
70. Next-generation AAV vectors-do not judge a virus (only) by its cover. Domenger C; Grimm D Hum Mol Genet; 2019 Oct; 28(R1):R3-R14. PubMed ID: 31261383 [TBL] [Abstract][Full Text] [Related]
71. A Preclinical Study in Rhesus Macaques for Cystic Fibrosis to Assess Gene Transfer and Transduction by AAV1 and AAV5 with a Dual-Luciferase Reporter System. Guggino WB; Benson J; Seagrave J; Yan Z; Engelhardt J; Gao G; Conlon TJ; Cebotaru L Hum Gene Ther Clin Dev; 2017 Sep; 28(3):145-156. PubMed ID: 28726496 [TBL] [Abstract][Full Text] [Related]
73. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease. Janelidze S; Nordström U; Kügler S; Brundin P J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717 [TBL] [Abstract][Full Text] [Related]
74. Surface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2/Vp3 and Vp3-only capsids but not that of fivefold pore mutant virions. Grieger JC; Johnson JS; Gurda-Whitaker B; Agbandje-McKenna M; Samulski RJ J Virol; 2007 Aug; 81(15):7833-43. PubMed ID: 17507473 [TBL] [Abstract][Full Text] [Related]
75. Cross-presentation of adeno-associated virus serotype 2 capsids activates cytotoxic T cells but does not render hepatocytes effective cytolytic targets. Wang L; Figueredo J; Calcedo R; Lin J; Wilson JM Hum Gene Ther; 2007 Mar; 18(3):185-94. PubMed ID: 17324107 [TBL] [Abstract][Full Text] [Related]
76. [Recombinant adeno-associated virus vector related impurities]. Diao Y; Wang Q; Xiao W; Xu R Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):717-23. PubMed ID: 21845838 [TBL] [Abstract][Full Text] [Related]
77. Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction. Naumer M; Popa-Wagner R; Kleinschmidt JA J Gen Virol; 2012 Oct; 93(Pt 10):2131-2141. PubMed ID: 22764318 [TBL] [Abstract][Full Text] [Related]